Clinical Trial Update: The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

Clinical trial update describing ongoing Phase 4 evaluation of inetetamab in first-line HER2-positive metastatic breast cancer, assessing different combination …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inetetamab (inetetamab)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Metastatic Breast Cancer | Phase 4 | Status: RECRUITING